HEALTHCARE GLOBAL ENTERPRISES Q2 FY27 CONCALL: GUIDES MID-TEENS ORGANIC REVENUE GROWTH & HIGH-TEENS TO 20% EBITDA GROWTH; TARGETS NORTH BANGALORE BREAKEVEN & GUJARAT RECOVERY BY Q4 FY27, EXPECTS DRUG MARGIN CAP IMPACT TO BE OFFSET FROM FY28